Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Cell Carcinoma of the Head and Neck Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07106827
What this trial is testing

GV20-0251 in Advanced or Refractory Solid Tumors

Who this might be right for
HCC - Hepatocellular CarcinomaCholangiocarcinomaMelanoma+5 more
West China Hospital 10
Testing effectiveness (Phase 2)Study completedNCT00114283
What this trial is testing

Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Who this might be right for
Recurrent Salivary Gland CancerRecurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the Larynx+31 more
National Cancer Institute (NCI) 30
Not applicableUnknownNCT03418454
What this trial is testing

The Oral Microbiome as a Prognostic Tool in Oral Malignant and Premalignant Lesions and in Medication Related Osteonecrosis of the Jaw

Who this might be right for
Oral Squamous Cell CarcinomaMedication Related Osteonecrosis of the JawOral Epithelial Dysplasia
Barzilai Medical Center 150
Not applicableActive Not RecruitingNCT05743569
What this trial is testing

3D Specimen Maps for RT Planning

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell CarcinomaRadiation Therapy
Vanderbilt University Medical Center 13
Large-scale testing (Phase 3)Study completedNCT00021125
What this trial is testing

Radiation Therapy in Treating Patients With Head and Neck Cancer

Who this might be right for
Head and Neck CancerNon-melanomatous Skin Cancer
Medical Research Council 460
Not applicableUnknownNCT05927220
What this trial is testing

WORST PATTERN OF INVASION IN ORAL SQUAMOUS CELL CARCINOMA

Who this might be right for
Oral CancerOral Cavity CancerOral Squamous Cell Carcinoma
Armed Forces Institute of Pathology Rawalpindi 81
Early research (Phase 1)Study completedNCT01847326
What this trial is testing

Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer

Who this might be right for
Recurrent Salivary Gland CancerRecurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the Larynx+8 more
University of Chicago 48
Early research (Phase 1)Study completedNCT02876510
What this trial is testing

ACTolog in Patients With Solid Cancers

Who this might be right for
CancerSolid Tumor
Immatics US, Inc. 38
Testing effectiveness (Phase 2)UnknownNCT03771820
What this trial is testing

Combination Therapy With NC-6004 and Pembrolizumab in Head and Neck Cancer Subjects Who Have Failed Platinum Regimen

Who this might be right for
SCCHN
NanoCarrier Co., Ltd. 136
Not applicableLooking for participantsNCT05854823
What this trial is testing

The Efficacy and Safety of De-escalated Postoperative Radiotherapy in Locally Advanced HNSCC With pCR/MPR

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Fifth Affiliated Hospital, Sun Yat-Sen University 23
Testing effectiveness (Phase 2)Looking for participantsNCT07513389
What this trial is testing

Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION)

Who this might be right for
Squamous Cell CarcinomaHuman Papilloma Virus (HPV)Oropharyngeal Squamous Cell Carcinoma (OPSCC)
Medical University of South Carolina 36
Testing effectiveness (Phase 2)Looking for participantsNCT04988074
What this trial is testing

Trial of Cemiplimab, or Cemip-Chemo Followed by Biomarker-guided Treatment for Pts w/HPV H&N Ca

Who this might be right for
HPV-Related Squamous Cell Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 32
Not applicableWithdrawnNCT00372450
What this trial is testing

Plastic Stents Compared With Metal Stents in Treating Patients With Malignant Dysphagia Caused by Esophageal Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Esophageal CancerGastrointestinal Complications
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT00003443
What this trial is testing

Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)UnknownNCT03024489
What this trial is testing

Palbociclib With Cetuximab and IMRT for Locally Advanced Squamous Cell Carcinoma

Who this might be right for
Head and Neck CancerLocally Advanced
Mahidol University 27
Not applicableStudy completedNCT00068497
What this trial is testing

Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer

Who this might be right for
Anaplastic Thyroid CancerInsular Thyroid CancerMetastatic Parathyroid Cancer+83 more
National Cancer Institute (NCI) 40
Not applicableLooking for participantsNCT06727162
What this trial is testing

The Value of CEUS in Assessing the Response of Cervical Lymph Nodes After NACI for HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 100
Not applicableStudy completedNCT02999646
What this trial is testing

Personalized and Cell-based Antitumor Immunization MVX-ONCO-1 in Advanced HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Maxivax SA 16
Large-scale testing (Phase 3)UnknownNCT00041613
What this trial is testing

Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate

Who this might be right for
Carcinoma, Squamous Cell
Introgen Therapeutics
Early research (Phase 1)Study completedNCT03517488
What this trial is testing

XmAb®20717 in Subjects With Selected Advanced Solid Tumors

Who this might be right for
MelanomaBreast CarcinomaHepatocellular Carcinoma+25 more
Xencor, Inc. 150
Next Page